In stock for ordering This guide is for physicians using medication-assisted treatment for patients with opioid use disorder. It discusses various types of approved medications, screening and assessment tools, and best practices for patient care. Publication ID SMA16-4892PG Publication Date March 2016 Format Guidelines or Manual Download MAT & Opioid Use Disorder (Pocket Guide) PDF 1.34 MB Order Print Publication Quantity Max Order Limit 5 Orders exceeding the maximum quantity limit require authorization. Find Related Information Audience Professional Care Providers Population Group People with Substance Use or Abuse Problems as Population Group You May Also Be Interested In TIP 63: Medications for Opioid Use Disorder – Pharmacotherapy for Opioid Use Disorder (Part 3 of 5) Part 3 of this Treatment Improvement Protocol (TIP) describes general principles of opioid use disorder (OUD) pharmacotherapy and discusses medication formulations, indications, and dosing for the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine. Part 3 also discusses patient management and monitoring in outpatient settings other than opioid treatment programs (OTPs) as well as medical management of patients with OUD in hospital settings. Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder. TIP 63: Medications for Opioid Use Disorder – Full Document (Including Executive Summary and Parts 1-5) This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. TIP 63: Medications for Opioid Use Disorder – Introduction to Medications for Opioid Use Disorder Treatment (Part 1 of 5) Part 1 of this Treatment Improvement Protocol (TIP) offers a general introduction to providing medications to address opioid use disorder (OUD). It is for all audiences. Part 1 will help readers understand key facts and issues related to providing Food and Drug Administration (FDA)-approved medications used to treat OUD. TIP Parts 2 through 5 cover these issues in more detail. Behavioral Health Barometer, Volume 5 The National report presents indicators as measured through the 2017 National Survey on Drug Use and Health and the National Survey of Substance Abuse Treatment Services. State reports provide a snapshot of substance use and mental health in the United States. Behavioral Health Barometer, 2015 This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. Access state barometer reports.